FDA delays mifepristone safety review until March, won't impose new restrictions yet

The Food and Drug Administration (FDA) won’t publish its safety review of the abortion drug mifepristone until March, it disclosed in a Wednesday court filing, adding that it won’t impose any new restrictions on the pill before that point. The revelations are likely to further anger anti-abortion…

Dumpster Fire links to reporting from The Hill. We don’t rewrite the facts; the original story is one click away.